These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16336218)

  • 21. Conantokin-G selectively inhibits N-methyl-D-aspartate-induced currents in Xenopus oocytes injected with mouse brain mRNA.
    Hammerland LG; Olivera BM; Yoshikami D
    Eur J Pharmacol; 1992 Jul; 226(3):239-44. PubMed ID: 1358659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subtype-selective antagonism of N-methyl-D-aspartate receptor ion channels by synthetic conantokin peptides.
    Sheng Z; Dai Q; Prorok M; Castellino FJ
    Neuropharmacology; 2007 Jul; 53(1):145-56. PubMed ID: 17588620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor.
    Masuko T; Nagaoka H; Miyake M; Metori K; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
    Neurochem Int; 2007 Jan; 50(2):443-9. PubMed ID: 17113196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memantine does not show intracellular block of the NMDA receptor channel.
    Parsons CG; Gilling KE; Jatzke C
    Eur J Pharmacol; 2008 Jun; 587(1-3):99-103. PubMed ID: 18456253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.
    Schotanus SM; Chergui K
    Eur J Neurosci; 2008 Apr; 27(8):1957-64. PubMed ID: 18412616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
    Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
    J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of delta2 glutamate receptors: effects of pentamidine and protons.
    Williams K; Dattilo M; Sabado TN; Kashiwagi K; Igarashi K
    J Pharmacol Exp Ther; 2003 May; 305(2):740-8. PubMed ID: 12606689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conantokins: peptide antagonists of NMDA receptors.
    Layer RT; Wagstaff JD; White HS
    Curr Med Chem; 2004 Dec; 11(23):3073-84. PubMed ID: 15579001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of agmatine on heteromeric N-methyl-D-aspartate receptor channels.
    Askalany AR; Yamakura T; Petrenko AB; Kohno T; Sakimura K; Baba H
    Neurosci Res; 2005 Aug; 52(4):387-92. PubMed ID: 15982768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-methyl-D-aspartate receptor-dependent long-term potentiation in CA1 region affects synaptic expression of glutamate receptor subunits and associated proteins in the whole hippocampus.
    Zhong WX; Dong ZF; Tian M; Cao J; Xu L; Luo JH
    Neuroscience; 2006 Sep; 141(3):1399-413. PubMed ID: 16766131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors.
    Kashiwagi K; Tanaka I; Tamura M; Sugiyama H; Okawara T; Otsuka M; Sabado TN; Williams K; Igarashi K
    J Pharmacol Exp Ther; 2004 Jun; 309(3):884-93. PubMed ID: 14764657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands.
    Hatton CJ; Paoletti P
    Neuron; 2005 Apr; 46(2):261-74. PubMed ID: 15848804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lead inhibition of N-methyl-D-aspartate receptors containing NR2A, NR2C and NR2D subunits.
    Omelchenko IA; Nelson CS; Allen CN
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1458-64. PubMed ID: 9316859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential modulation of human N-methyl-D-aspartate receptors by structurally diverse general anesthetics.
    Solt K; Eger EI; Raines DE
    Anesth Analg; 2006 May; 102(5):1407-11. PubMed ID: 16632818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CGX-1007 prevents excitotoxic cell death via actions at multiple types of NMDA receptors.
    Alex AB; Saunders GW; Dalpé-Charron A; Reilly CA; Wilcox KS
    Neurotoxicology; 2011 Aug; 32(4):392-9. PubMed ID: 21396956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subunit-specific effects of poricoic acid A on NMDA receptors.
    Lee J; Kim C; Yeom HD; Nguyen KVA; Eom S; Lee S; Jung JH; Lee JH; Kim SH; Kim IK; Lee JH
    Pharmacol Rep; 2020 Apr; 72(2):472-480. PubMed ID: 32048268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMDA receptor subtypes at autaptic synapses of cerebellar granule neurons.
    Lu C; Fu Z; Karavanov I; Yasuda RP; Wolfe BB; Buonanno A; Vicini S
    J Neurophysiol; 2006 Nov; 96(5):2282-94. PubMed ID: 16885526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoamines directly inhibit N-methyl-D-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner.
    Masuko T; Suzuki I; Kizawa Y; Kusama-Eguchi K; Watanabe K; Kashiwagi K; Igarashi K; Kusama T
    Neurosci Lett; 2004 Nov; 371(1):30-3. PubMed ID: 15500961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicity of beta-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-D-aspartate receptor subunits.
    Domingues A; Almeida S; da Cruz e Silva EF; Oliveira CR; Rego AC
    Neurochem Int; 2007 May; 50(6):872-80. PubMed ID: 17403555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temperature dependence of NR1/NR2B NMDA receptor channels.
    Cais O; Sedlacek M; Horak M; Dittert I; Vyklicky L
    Neuroscience; 2008 Jan; 151(2):428-38. PubMed ID: 18068304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.